To investigate whether inflammation might contribute to decreased levels of MS mRNA, cultured human SH-SY5Y neuroblastoma cells were treated with TNF-α (30 ng/ml), and levels of cobalamin and cap domain-containing transcripts were measured at different time intervals. This evidence concerns the gene TNF and neuroblastoma.